Unknown

Dataset Information

Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin.


ABSTRACT:

SUBMITTER: Silva WFD 

PROVIDER: S-EPMC6978496 | biostudies-literature | 2019 Oct - Dec

REPOSITORIES: biostudies-literature